SCHEMBL324084

SCHEMBL324084

O=C(O)CCN1CCOC(c2ccc(Oc3cccc(C(F)(F)F)c3)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.49
LTA4H P09960 1/20 0.46
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
DRD3 P35462 7/20 0.42
DRD2 P14416 4/20 0.42
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
HTR2B P41595 1/20 0.41
FAAH O00519 1/20 0.41
MOGAT2 Q3SYC2 1/20 0.41
EPOR P19235 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
CHRM1 P11229 1/20 0.39
KCNH2 Q12809 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL324122 0.99 CNR2 (0.48) CNR2LTA4HKMT2AMEN1DRD3
SCHEMBL323951 0.91 CNR2 (0.47) CNR2KMT2AMEN1DRD3DRD2
Hydrochloric Acid SCHEMBL323146 0.90 CNR2 (0.46) CNR2KMT2AMEN1DRD3DRD2
SCHEMBL323516 0.90 CNR2 (0.49) CNR2KMT2AMEN1DRD3DRD2
Hydrochloric Acid SCHEMBL324780 0.89 CNR2 (0.48) CNR2KMT2AMEN1DRD3DRD2
SCHEMBL15153711 0.89 CNR2 (0.44) CNR2LTA4HKMT2AMEN1DRD3
SCHEMBL15153639 0.89 CNR2 (0.49) CNR2KMT2AMEN1DRD3DRD2
SCHEMBL15153611 0.88 MEN1 (0.45) CNR2KMT2AMEN1DRD3DRD2
Hydrochloric Acid SCHEMBL323216 0.88 CNR2 (0.48) CNR2KMT2AMEN1DRD3DRD2
SCHEMBL318954 0.87 CNR2 (0.52) CNR2KMT2AMEN1DRD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9662337-B2 Bisaryl (thio)morpholine derivatives as S1P modulators ABBVIE B.V. (NL) 2017-05-30 US claimed
US-20160151376-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE B.V. (NL) 2016-06-02 US claimed
EP-2590954-B1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE BV (NL) 2016-04-13 EP claimed
US-9029371-B2 Bisaryl (thio)morpholine derivatives as S1P modulators ABBVIE B.V. (NL) 2015-05-12 US claimed
US-20130203745-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE B.V. (NL) 2013-08-08 US claimed
EP-2590954-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE B.V. (NL) 2013-05-15 EP claimed
WO-2012004375-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBOTT HEALTHCARE PRODUCTS B.V. (NL) 2012-01-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203745-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS S1PR3, S1PR1, S1PR2 CNR2 9/4885LTA4H 1031/4885KMT2A 2525/4885
US-20160151376-A1 BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS S1PR1, S1PR3, S1PR2 CNR2 25/4885LTA4H 395/4885KMT2A 2862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.